Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Amortizatization of Intangibles (2023 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Amortizatization of Intangibles for 3 consecutive years, with $43359.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 6.83% year-over-year to $43359.0, compared with a TTM value of $169209.0 through Oct 2025, up 7.19%, and an annual FY2025 reading of $169209.0, up 7.19% over the prior year.
  • Amortizatization of Intangibles was $43359.0 for Q4 2025 at Pharma-Bio Serv, up from $42512.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $43359.0 in Q4 2025 and bottomed at $35431.0 in Q1 2023.
  • Average Amortizatization of Intangibles over 3 years is $39441.4, with a median of $39488.0 recorded in 2024.
  • Peak annual rise in Amortizatization of Intangibles hit 8.08% in 2025, while the deepest fall reached 6.8% in 2025.
  • Year by year, Amortizatization of Intangibles stood at $37553.0 in 2023, then grew by 8.08% to $40586.0 in 2024, then increased by 6.83% to $43359.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for PBSV at $43359.0 in Q4 2025, $42512.0 in Q3 2025, and $41952.0 in Q2 2025.